Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 32.39% is in line with its 5-year average of 32.02%, near the high end of its 5-year range (17.08%–37.77%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.00% below its 12-month average of 33.39%.
Reported quarterly debt to assets ratio; no daily interpolation.
DEBT TO ASSETS RATIO
32.39%
DEBT TO ASSETS RATIO AVG TTM
33.39%
DEBT TO ASSETS RATIO AVG 3Y
33.97%
DEBT TO ASSETS RATIO AVG 5Y
32.02%
DEBT TO ASSETS RATIO AVG 10Y
28.52%
DEBT TO ASSETS RATIO AVG 15Y
30.72%
DEBT TO ASSETS RATIO AVG 20Y
29.33%
CURRENT VS TTM AVG
-3.00%
CURRENT VS 3Y AVG
-4.64%
CURRENT VS 5Y AVG
+1.15%
CURRENT VS 10Y AVG
+13.57%
CURRENT VS 15Y AVG
+5.44%
CURRENT VS 20Y AVG
+10.42%
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 83 covered companies
CURRENT VS SECTOR MEDIAN
+11068.16%
vs the sector median at left
Roche Holding AG
Market Cap
$359.46B
Debt to Assets Ratio
32.39%
TTM Avg
33.39%
3Y Avg
33.97%
5Y Avg
32.02%
Market Cap
$358.76B
Debt to Assets Ratio
0.24%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$234.38B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$193.04B
Debt to Assets Ratio
0.30%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Roche Holding AG (RHHBY) | $359.46B | 32.39% | 33.39% | 33.97% | 32.02% |
| UnitedHealth Group Incorporated (UNH)vs › | $358.76B | 0.24% | N/A | N/A | N/A |
| Merck & Co., Inc. (MRK)vs › | $369.34B | 0.42% | N/A | N/A | N/A |
| AbbVie Inc. (ABBV)vs › | $455.87B | 0.52% | N/A | N/A | N/A |
| AstraZeneca PLC (AZN)vs › | $255.15B | 0.28% | N/A | N/A | N/A |
| Amgen Inc. (AMGN)vs › | $235.85B | 0.60% | N/A | N/A | N/A |
| Thermo Fisher Scientific Inc. (TMO)vs › | $234.38B | 0.38% | N/A | N/A | N/A |
| Novo Nordisk A/S (NVO)vs › | $205.42B | 0.24% | N/A | N/A | N/A |
| Abbott Laboratories (ABT)vs › | $193.04B | 0.30% | N/A | N/A | N/A |
| Gilead Sciences, Inc. (GILD)vs › | $184.82B | 0.53% | N/A | N/A | N/A |
Debt/Assets
32.4%
Debt/Equity
0.97
Current Ratio
1.23
Interest Coverage
14.3x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 32.39% |
| 2025-12-31 | 32.92% |
| 2025-06-30 | 34.86% |
| 2024-12-31 | 35.71% |
| 2024-06-30 | 37.77% |
| 2023-12-31 | 34.03% |
| 2023-06-30 | 30.09% |
| 2022-12-31 | 30.11% |
| 2022-06-30 | 31.99% |
| 2021-12-31 | 35.26% |
| 2021-06-30 | 17.08% |
| 2020-12-31 | 17.89% |
| 2020-06-30 | 18.72% |
| 2019-12-31 | 18.75% |
| 2019-06-30 | 24.40% |
| 2018-12-31 | 23.91% |
| 2018-06-30 | 26.50% |
| 2017-12-31 | 24.73% |
| 2017-06-30 | 29.39% |
| 2016-12-31 | 29.10% |
| 2016-06-30 | 33.30% |
| 2015-12-31 | 30.69% |
| 2015-06-30 | 34.98% |
| 2014-12-31 | 34.04% |
| 2014-06-30 | 30.76% |
| 2013-12-31 | 30.05% |
| 2013-06-30 | 35.99% |
| 2012-12-31 | 37.94% |
| 2012-06-30 | 44.55% |
| 2011-12-31 | 43.61% |
| 2011-06-30 | 47.42% |
| 2010-12-31 | 49.26% |
| 2010-06-30 | 57.07% |
| 2009-12-31 | 56.88% |
| 2009-06-30 | 67.59% |
| 2008-12-31 | 5.37% |
| 2008-06-30 | 7.91% |
| 2007-12-31 | 8.78% |
| 2007-06-30 | 9.97% |
| 2006-12-31 | 11.08% |
| 2005-12-31 | 13.94% |
| 2004-12-31 | 15.43% |
| 2003-12-31 | 25.70% |
| 2002-12-31 | 34.92% |
| 2001-12-31 | 31.52% |
| 2000-12-31 | 31.09% |
| 1999-12-31 | 34.54% |
| 1998-12-31 | 35.98% |
